Compare Immunovant Inc. Common Stock (IMVT) vs Southern Company (SO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Southern Company — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Southern Company trades at $86.29 (market cap $98.29B). The key difference: Southern Company is far larger — about 14.8× Immunovant Inc. Common Stock's market cap, and Southern Company pays a 3.56% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Southern Company for 12 Days on average.
| IMVT | SO | |
|---|---|---|
Market Cap | $6.62B | $98.29B |
Volume | 1,131,364 | 5,624,994 |
Sector | Health | Utilities |
52-Week High | $44.96 | $99.72 |
52-Week Low | $17.03 | $82.35 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $5.72B | $172.39B |
Dividend Yield | — | 3.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Southern Company
Southern Company is a U.S. energy company with electric and gas utility businesses. Its power generation portfolio includes natural gas, nuclear, renewable, and other energy sources.
Read more on SO →
